Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Acquisitions (2018)

Sunshine Biopharma's Acquisitions history spans 1 years, with the latest figure at $9884.0 for Q4 2018.

  • For Q4 2018, Acquisitions changed N/A year-over-year to $9884.0; the TTM value through Sep 2019 reached $9884.0, up 300.0%, while the annual FY2022 figure was $14.3 million, N/A changed from the prior year.
  • Acquisitions reached $9884.0 in Q4 2018 per SBFM's latest filing, up from -$85231.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $80289.0 in Q1 2018 to a low of -$85231.0 in Q3 2018.